Integrating Imaging Genomic Data in the Quest for Biomarkers of Schizophrenia Disease

It's increasingly important but difficult to determine potential biomarkers of schizophrenia (SCZ) disease, owing to the complex pathophysiology of this disease. In this study, a network-fusion based framework was proposed to identify genetic biomarkers of the SCZ disease. A three-step feature selection was applied to single nucleotide polymorphisms (SNPs), DNA methylation, and functional magnetic resonance imaging (fMRI) data to select important features, which were then used to construct two gene networks in different states for the SNPs and DNA methylation data, respectively. Two health networks (one is for SNP data and the other is for DNA methylation data) were combined into one health network from which health minimum spanning trees (MSTs) were extracted. Two disease networks also followed the same procedures. Those genes with significant changes were determined as SCZ biomarkers by comparing MSTs in two different states and they were finally validated from five aspects. The effectiveness of the proposed discovery framework was also demonstrated by comparing with other network-based discovery methods. In summary, our approach provides a general framework for discovering gene biomarkers of the complex diseases by integrating imaging genomic data, which can be applied to the diagnosis of the complex diseases in the future.

[1]  D.-S. Huang,et al.  Radial Basis Probabilistic Neural Networks: Model and Application , 1999, Int. J. Pattern Recognit. Artif. Intell..

[2]  Natasa Przulj,et al.  Biological network comparison using graphlet degree distribution , 2007, Bioinform..

[3]  Bernhard Bogerts,et al.  Morphometric analysis of the cerebral expression of ATP-binding cassette transporter protein ABCB1 in chronic schizophrenia: Circumscribed deficits in the habenula , 2016, Schizophrenia Research.

[4]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[5]  Li Wang,et al.  An integrative approach for causal gene identification and gene regulatory pathway inference , 2006, ISMB.

[6]  Teresa M. Przytycka,et al.  Identifying Causal Genes and Dysregulated Pathways in Complex Diseases , 2011, PLoS Comput. Biol..

[7]  Gábor Csárdi,et al.  The igraph software package for complex network research , 2006 .

[8]  R. Myers,et al.  Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder , 2015, Translational Psychiatry.

[9]  Seth Pettie,et al.  Minimizing randomness in minimum spanning tree, parallel connectivity, and set maxima algorithms , 2002, SODA '02.

[10]  C. Turck Biomarkers for Psychiatric Disorders , 2009 .

[11]  T. Ideker,et al.  Modeling cellular machinery through biological network comparison , 2006, Nature Biotechnology.

[12]  Takashi Uehara,et al.  Specific gene expression patterns of 108 schizophrenia-associated loci in cortex , 2016, Schizophrenia Research.

[13]  Sharon C. Lyter,et al.  Diagnostic and Statistical Manual of Mental Disorders: Making it Work for Social Work , 2012 .

[14]  Guofu Zhang,et al.  The mRNA expression of DRD2, PI3KCB, and AKT1 in the blood of acute schizophrenia patients , 2016, Psychiatry Research.

[15]  Vincent Magnotta,et al.  Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. , 2003, Archives of general psychiatry.

[16]  S. Faraone,et al.  Genes, environment and schizophrenia. , 2001, The British journal of psychiatry. Supplement.

[17]  John P A Ioannidis,et al.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database , 2008, Nature Genetics.

[18]  Harish Padh,et al.  Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[19]  Miguel Bernardo,et al.  Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia. , 2016, Journal of psychiatry & neuroscience : JPN.

[20]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[21]  Zhen Wang,et al.  SFAPS: An R package for structure/function analysis of protein sequences based on informational spectrum method , 2013, 2013 IEEE International Conference on Bioinformatics and Biomedicine.

[22]  Gary D. Bader,et al.  The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function , 2010, Nucleic Acids Res..

[23]  A. Vita,et al.  Schizophrenia , 2016, The Lancet.

[24]  Junfeng Xia,et al.  Identification of ovarian cancer subtype-specific network modules and candidate drivers through an integrative genomics approach , 2015, Oncotarget.

[25]  Vince D. Calhoun,et al.  Sparse models for correlative and integrative analysis of imaging and genetic data , 2014, Journal of Neuroscience Methods.

[26]  Roded Sharan,et al.  Associating Genes and Protein Complexes with Disease via Network Propagation , 2010, PLoS Comput. Biol..

[27]  Ying Xu,et al.  Clustering gene expression data using a graph-theoretic approach: an application of minimum spanning trees , 2002, Bioinform..

[28]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[29]  Falk Schreiber,et al.  Exploration of biological network centralities with CentiBiN , 2006, BMC Bioinformatics.

[30]  Hao He,et al.  Integrative analysis of multiple diverse omics datasets by sparse group multitask regression , 2014, Front. Cell Dev. Biol..

[31]  Bing Zhang,et al.  WebGestalt: an integrated system for exploring gene sets in various biological contexts , 2005, Nucleic Acids Res..

[32]  Scott J. Myers,et al.  Human GRIN2B variants in neurodevelopmental disorders , 2016, Journal of pharmacological sciences.

[33]  Dennis Velakoulis,et al.  Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. , 2005, Schizophrenia bulletin.

[34]  Sophie K. Scott,et al.  Functional imaging and language: A critical guide to methodology and analysis , 2003, Speech Commun..

[35]  Hong Jin Jeon,et al.  Effects of LEP, LEPR, ADIPOQ, MC4R and FTO polymorphisms on dyslipidemia in Korean patients with schizophrenia who are taking clozapine , 2015, Psychiatry Research.

[36]  Dietrich Rebholz-Schuhmann,et al.  Biological network extraction from scientific literature: state of the art and challenges , 2014, Briefings Bioinform..

[37]  De-Shuang Huang,et al.  A Constructive Hybrid Structure Optimization Methodology for Radial Basis Probabilistic Neural Networks , 2008, IEEE Transactions on Neural Networks.

[38]  A. Nishi,et al.  Potential for targeting dopamine/DARPP-32 signaling in neuropsychiatric and neurodegenerative disorders , 2017, Expert opinion on therapeutic targets.

[39]  D. Javitt,et al.  BRAIN IMAGING NEUROREPORT , 2005 .

[40]  Yan Zhang,et al.  Research and applications: An integrated approach to identify causal network modules of complex diseases with application to colorectal cancer , 2013, J. Am. Medical Informatics Assoc..

[41]  Giuseppe Blasi,et al.  Imaging genomics and response to treatment with antipsychotics in schizophrenia , 2011, NeuroRX.

[42]  R. Prim Shortest connection networks and some generalizations , 1957 .

[43]  R. Murray,et al.  Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. , 2000, Archives of general psychiatry.

[44]  Jorge Amigo,et al.  Targeted resequencing of regulatory regions at schizophrenia risk loci: Role of rare functional variants at chromatin repressive states , 2016, Schizophrenia Research.

[45]  J. Ballenger,et al.  At-Risk Variant in TCF7L2 for Type II Diabetes Increases Risk of Schizophrenia , 2012 .

[46]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[47]  Hae Jeong Park,et al.  Association between promoter polymorphisms of the LIFR gene and schizophrenia with persecutory delusion in a Korean population. , 2011, Molecular medicine reports.

[48]  R. Kikinis,et al.  A review of diffusion tensor imaging studies in schizophrenia. , 2007, Journal of psychiatric research.

[49]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[50]  Sisi Jiang,et al.  Evidence for Association of Cell Adhesion Molecules Pathway and NLGN1 Polymorphisms with Schizophrenia in Chinese Han Population , 2015, PloS one.

[51]  C. Zheng,et al.  Identification of driver pathways in cancer based on combinatorial patterns of somatic gene mutations. , 2016, Neoplasma.

[52]  De-Shuang Huang,et al.  Predicting Hub Genes Associated with Cervical Cancer through Gene Co-Expression Networks , 2016, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[53]  Paul M Thompson,et al.  Imaging genomics: Mapping the influence of genetics on brain structure and function , 2007, Human brain mapping.

[54]  Christine Klein,et al.  Mapping preclinical compensation in Parkinson's disease: An imaging genomics approach , 2009, Movement disorders : official journal of the Movement Disorder Society.

[55]  Martin G. Everett,et al.  A Graph-theoretic perspective on centrality , 2006, Soc. Networks.

[56]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[57]  Norio Ozaki,et al.  Association of the HSPG2 Gene with Neuroleptic-Induced Tardive Dyskinesia , 2010, Neuropsychopharmacology.

[58]  R. Tibshirani,et al.  A penalized matrix decomposition, with applications to sparse principal components and canonical correlation analysis. , 2009, Biostatistics.

[59]  Mukesh Verma,et al.  The promise of biomarkers in cancer screening and detection. , 2002, Trends in molecular medicine.

[60]  Hiroki Shimada,et al.  The Suppression of Maternal–Fetal Leukemia Inhibitory Factor Signal Relay Pathway by Maternal Immune Activation Impairs Brain Development in Mice , 2015, PloS one.

[61]  Fidel Ramírez,et al.  Computing topological parameters of biological networks , 2008, Bioinform..

[62]  Leif E. Peterson K-nearest neighbor , 2009, Scholarpedia.

[63]  Toshiyuki Someya,et al.  A missense mutation in the ITGA8 gene, a cell adhesion molecule gene, is associated with schizophrenia in Japanese female patients , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[64]  Greg N. Frederickson,et al.  Data Structures for On-Line Updating of Minimum Spanning Trees, with Applications , 1985, SIAM J. Comput..

[65]  Ho-Min Tsai,et al.  Genetic analysis of GABRB3 at 15q12 as a candidate gene of schizophrenia , 2014, Psychiatric genetics.

[66]  Jim van Os,et al.  The environment and schizophrenia , 2010, Nature.

[67]  Daniela M Witten,et al.  Extensions of Sparse Canonical Correlation Analysis with Applications to Genomic Data , 2009, Statistical applications in genetics and molecular biology.

[68]  Bente Pakkenberg,et al.  Expression of presynaptic markers in a neurodevelopmental animal model with relevance to schizophrenia , 2013, Neuroreport.

[69]  Nicholas G Martin,et al.  Imaging genomics. , 2010, Current opinion in neurology.

[70]  Dongdong Lin,et al.  Integrating fMRI and SNP data for biomarker identification for schizophrenia with a sparse representation based variable selection method , 2013, BMC Medical Genomics.

[71]  D. Tritchler,et al.  Sparse Canonical Correlation Analysis with Application to Genomic Data Integration , 2009, Statistical applications in genetics and molecular biology.

[72]  Ronald Pies,et al.  How "objective" are psychiatric diagnoses?: (guess again). , 2007, Psychiatry (Edgmont (Pa. : Township)).

[73]  Ales Belic,et al.  Optimization of Clonazepam Therapy Adjusted to Patient’s CYP3A Status and NAT2 Genotype , 2016, The international journal of neuropsychopharmacology.

[74]  De-Shuang Huang,et al.  A General CPL-AdS Methodology for Fixing Dynamic Parameters in Dual Environments , 2012, IEEE Transactions on Systems, Man, and Cybernetics, Part B (Cybernetics).

[75]  Susanna Cirera,et al.  An integrative systems genetics approach reveals potential causal genes and pathways related to obesity , 2015, Genome Medicine.

[76]  H. Hotelling Relations Between Two Sets of Variates , 1936 .

[77]  Yoshiro Okubo,et al.  Interaction effect between handedness and CNTNAP2 polymorphism (rs7794745 genotype) on voice-specific frontotemporal activity in healthy individuals: an fMRI study , 2015, Front. Behav. Neurosci..

[78]  De-Shuang Huang,et al.  Mining the bladder cancer-associated genes by an integrated strategy for the construction and analysis of differential co-expression networks , 2015, BMC Genomics.

[79]  S. Mccarroll,et al.  Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1–PAK3 signaling in neuroplasticity , 2017, Molecular Psychiatry.

[80]  Philip N. Klein,et al.  A randomized linear-time algorithm to find minimum spanning trees , 1995, JACM.

[81]  Alessio Squassina,et al.  Linkage of M5 Muscarinic and α7-Nicotinic Receptor Genes on 15q13 to Schizophrenia , 2004, Neuropsychobiology.

[82]  Ralf Herwig,et al.  The ConsensusPathDB interaction database: 2013 update , 2012, Nucleic Acids Res..

[83]  J. Fullerton,et al.  Elevated ErbB4 mRNA is related to interneuron deficit in prefrontal cortex in schizophrenia. , 2014, Journal of psychiatric research.

[84]  Junfeng Xia,et al.  LNDriver: identifying driver genes by integrating mutation and expression data based on gene-gene interaction network , 2016, BMC Bioinformatics.

[85]  P. Bourgine,et al.  Topological and causal structure of the yeast transcriptional regulatory network , 2002, Nature Genetics.

[86]  Zhu-Hong You,et al.  Increasing the reliability of protein-protein interaction networks via non-convex semantic embedding , 2013, Neurocomputing.

[87]  Mario Falchi,et al.  Genome-wide Association Study Identifies Genes for Biomarkers of Cardiovascular Disease: Serum Urate and Dyslipidemia , 2022 .

[88]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[89]  X Li,et al.  The early growth response protein 1-miR-30a-5p-neurogenic differentiation factor 1 axis as a novel biomarker for schizophrenia diagnosis and treatment monitoring , 2017, Translational Psychiatry.

[90]  De-Shuang Huang,et al.  ChIP-PIT: Enhancing the Analysis of ChIP-Seq Data Using Convex-Relaxed Pair-Wise Interaction Tensor Decomposition , 2016, IEEE/ACM Transactions on Computational Biology and Bioinformatics.